CRISTY KU to Retinal Degeneration
This is a "connection" page, showing publications CRISTY KU has written about Retinal Degeneration.
Connection Strength
2.195
-
The Role of ERK1/2 Activation in Sarpogrelate-Mediated Neuroprotection. Invest Ophthalmol Vis Sci. 2018 01 01; 59(1):462-471.
Score: 0.539
-
Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration. JAMA Ophthalmol. 2017 07 01; 135(7):749-760.
Score: 0.521
-
Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia. Ophthalmic Genet. 2016 12; 37(4):404-414.
Score: 0.476
-
Gene Therapy Trial Update: A Primer for Vitreoretinal Specialists. Ophthalmic Surg Lasers Imaging Retina. 2016 Jan; 47(1):6-12.
Score: 0.470
-
Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2015 Jul; 56(8):4560-9.
Score: 0.113
-
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5. Am J Ophthalmol. 2022 08; 240:285-301.
Score: 0.045
-
Molecular and Clinical Findings in Patients With Knobloch Syndrome. JAMA Ophthalmol. 2016 07 01; 134(7):753-62.
Score: 0.030